UNIVERSITY OF ALABAMA AT BIRMINGHAM
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1969-01-01
- Employees
- 2K
- Market Cap
- -
- Website
- http://www.uab.edu
Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and Vomiting
Phase 2
Withdrawn
- Conditions
- Chemotherapy-induced Nausea and Vomiting
- Interventions
- First Posted Date
- 2019-09-11
- Last Posted Date
- 2020-09-30
- Lead Sponsor
- University of Alabama at Birmingham
- Registration Number
- NCT04085393
- Locations
- 🇺🇸
The University of Alabama at Birmingham, Birmingham, Alabama, United States
Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV)
Early Phase 1
Recruiting
- Conditions
- Influenza, Human
- Interventions
- Biological: Treatment Group Live Attenuated Flu Vaccine (LAIV)
- First Posted Date
- 2019-09-06
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 18
- Registration Number
- NCT04080245
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Ketone Supplementation in Adolescents Post-Concussion
Not Applicable
Completed
- Conditions
- Concussion, MildConcussion, SevereSports Injuries in ChildrenConcussion, BrainConcussive InjurySport Injury
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Ketone
- First Posted Date
- 2019-09-06
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 5
- Registration Number
- NCT04079907
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Regional Block for Postoperative Free Flap Care
Phase 4
Completed
- Conditions
- Pain Management
- Interventions
- Drug: ropivicaine 0.2%
- First Posted Date
- 2019-09-06
- Last Posted Date
- 2023-12-06
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 100
- Registration Number
- NCT04080739
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Gout in the ED and Improving Research Participation
Not Applicable
Active, not recruiting
- Conditions
- Gout
- Interventions
- Behavioral: Storytelling
- First Posted Date
- 2019-09-03
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 200
- Registration Number
- NCT04075903
- Locations
- 🇺🇸
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸MetroHealth Medical Center, Cleveland, Ohio, United States
Feasibility of a New Model for Exercise Prescription in Cystic Fibrosis
Not Applicable
Recruiting
- Conditions
- Cystic Fibrosis
- Interventions
- Behavioral: Behavioral Counseling and Exercise
- First Posted Date
- 2019-09-03
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 12
- Registration Number
- NCT04075864
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
The Multicenter Topic Trial
- First Posted Date
- 2019-08-26
- Last Posted Date
- 2022-01-27
- Lead Sponsor
- University of Alabama at Birmingham
- Registration Number
- NCT04066751
Efficacy of BIPAMS for Restless Legs Syndrome in Adults With Multiple Sclerosis: A Pilot Study
Not Applicable
Completed
- Conditions
- Restless Legs SyndromeMultiple Sclerosis
- Interventions
- Behavioral: Behavioral Intervention (BIPAMS)
- First Posted Date
- 2019-08-20
- Last Posted Date
- 2020-12-11
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 15
- Registration Number
- NCT04061681
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders
Not Applicable
Recruiting
- Conditions
- Movement Disorders
- Interventions
- Procedure: Response Inhibition and Deep Brain Stimulation in Parkinson's disease
- First Posted Date
- 2019-08-19
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 90
- Registration Number
- NCT04061135
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
Phase 2
Recruiting
- Conditions
- Cardiovascular DiseasesDiabetes MellitusInsulin Sensitivity/ResistanceMetabolismEnergy ExpenditureMetabolic DiseaseNatriuretic Peptides
- Interventions
- Drug: Sacubitril, Valsartan 97-103 mg Oral TabletOther: Intravenous Glucose Tolerance TestDietary Supplement: Standardized MealsOther: Exercise capacity VO2 maximum determination
- First Posted Date
- 2019-08-13
- Last Posted Date
- 2024-07-09
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 200
- Registration Number
- NCT04055428
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
© Copyright 2025. All Rights Reserved by MedPath